期刊文献+

复方中药对亚临床肝性脑病治疗作用临床研究 被引量:4

A Clinical Study on Therapeutic Effect of Chinese Traditional Compound Medicine on Subclinical Hepatic Encephalopathy
下载PDF
导出
摘要 目的观察复方中药对亚临床肝性脑病(SHE)的治疗作用。方法将52例肝硬化伴亚临床肝性脑病病例随机分为治疗组和对照组,对照组接受常规护肝治疗,治疗组在常规治疗的基础上,加用复方中药水煎剂。2周为1疗程,观察患者的数字连接试验(NCT)、脑电图(EEG)、肝功能、血氨等的改善情况。结果治疗组的NCT时间、脑电图以及肝功能血氨等生化指标较对照组改善,两组比较,有显著性差异(P<0·01)。结论由虎杖、生山楂、酸枣仁、蒲公英、石菖蒲等组成的复方中药对亚临床肝性脑病患者有显著疗效。 Objective To observe the therapeutic effects of Chinese traditional compound medicine on subcilincal hepatic encephalopathy(SHE). Methods 52 patients with liver cirrhosis complicated by SHE were randomly divided into treatment group and control group. The patients of control group received conventional hepatopretection treatment, and the patients of treatment group were given conventional treatment and Chinese traditional compound medicines. Number connection test( NCT), electroencephalogram (EEG), liver function, blood ammonia were investigated after 2 weeks of treatment. Resuhs The number connection test ( NCT), electroencephalogram (EEG) ,liver function,blood ammonia were significantly improved in the treatment group than that in the control group( P 〈 0.01 ). Conclusion The effects of the Chinese traditional compound medicines ( compose of Polygonum cuspidatum, raw hawthornfruit, seed of Zizyphus jujuba Mill, Mongolian Dandelion Herb and Rhizoma Acoori Graminei ) in SHE treatment is significant.
出处 《医学研究杂志》 2006年第12期20-22,共3页 Journal of Medical Research
基金 浙江省中医药科技基金计划项目
关键词 复方中药 亚临床肝性脑病 治疗作用 Chinese traditional compound medicines Subclinical hepatic encephalopathy Theraputic effect
  • 相关文献

参考文献6

二级参考文献19

  • 1朱权,张兆文.亚临床肝性脑的心理测验与诱发电位检查诊断研究[J].中华内科杂志,1993,32(10):676-678. 被引量:15
  • 2贾林,李瑜元.亚临床型肝性脑病[J].中华内科杂志,1996,35(7):495-497. 被引量:49
  • 3龚耀先.中国修定韦氏成人智力量表(WAIS-RC)手册[M].长沙:湖南地图出版社,1992.52.
  • 4Groeneweg M, Quero JC, Bruijn ID, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology, 1998,28:45-49.
  • 5Saxena N, Bhatia M, Joshi YK, et al. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J Gastroenterol Hepatol, 2001,16, 322-327.
  • 6Romero-Gomez M, Boza F, Garcia-Valdecasas MS, et al.Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol, 2001,96: 2718-2723.
  • 7Watanabe A, Sakal T, Sato S, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology, 1997, 26:1410-1414.
  • 8Dhiman RK, Sawhney MS, Chawla YK, et al. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci, 2000,45 : 1549-1552.
  • 9王吉耀.全国肝硬化专题学术讨论会纪要[J].中华消化杂志,1991,11(5):290-290.
  • 10Saxena N, Bhatia M, Joshi YK, et al. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatical encephalopathy and prediction of overt encephalopathy. Liver, 2002, 22: 190-197.

共引文献14058

同被引文献71

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部